Aldeyra The (ALDX) vs Oncolytics Biotech Inc. (ONCY)
A side-by-side comparison of Aldeyra The and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.91HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
ONCY
Oncolytics Biotech Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — ALDX vs ONCY
growth of $100 · dividends reinvested · last 10yALDX -87.7% (-18.9%/yr)ONCY -76.8% (-13.6%/yr)ONCY compounded faster over this window
ALDX ONCY
ALDX vs ONCY: by the numbers
- •ONCY is the larger company ($60M vs $55M market cap).
Metrics side by side
Valuation
| Metric | ALDX | ONCY |
|---|---|---|
| P/B ratio | 1.45 | N/A |
Profitability
| Metric | ALDX | ONCY |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -60.85% | N/A |
| ROIC | -63.52% | -1235.48% |
Growth (annualized)
| Metric | ALDX | ONCY |
|---|---|---|
| Total return CAGR (5Y) | -36.54% | -21.00% |
Frequently asked
- How have ALDX and ONCY total returns compared?
- Over the past 10 years, ALDX delivered -18.91% and ONCY delivered -12.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.